New York, NY, August 28, 2017 – The American Parkinson Disease Association is pleased to share with the Parkinson’s...see more community the arrival of a new medication in the treatment arsenal to address Parkinson’s symptoms. Approved August 24 by the U.S. Food and Drug Administration is GOCOVRI™ (amantadine) developed by Adamas.  GOCOVRI is an extended release […]

Read More